Budget impact model of secukinumab for the treatment of moderate-to-severe psoriasis, psoriatic arthritis, and ankylosing spondylitis in Italy: a cross-indication initiative

Budget impact model of secukinumab for the treatment of moderate-to-severe psoriasis, psoriatic arthritis, and ankylosing spondylitis in Italy: a cross-indication initiative

Giorgio L Colombo,1,2 Sergio Di Matteo,2 Chiara Martinotti,2 Steffen M Jugl,3 Praveen Gunda,4 Mariantonietta Naclerio,5 Giacomo M Bruno2 1Department of Drug Science, Pavia University, Pavia, Italy; 2S.A.V.E. S.r.l. Studi Analisi Valutazioni Economiche Health Economics & Outcomes Research - r...

Full description

Bibliographic Details
Main Authors: Colombo GL, Di Matteo S, Martinotti C, Jugl SM, Gunda P, Naclerio M, Bruno GM
Format: Article
Language:English
Published: Dove Medical Press 2018-08-01
Series:ClinicoEconomics and Outcomes Research
Subjects:
Budget impact
Psoriasis
Psoriatic Arthritis
Ankylosing spondylitis
Italy
secukinumab
Online Access:https://www.dovepress.com/budget-impact-model-of-secukinumab-for-the-treatment-of-moderate-to-se-peer-reviewed-article-CEOR

Internet

https://www.dovepress.com/budget-impact-model-of-secukinumab-for-the-treatment-of-moderate-to-se-peer-reviewed-article-CEOR

Similar Items